MR
Muniswamy Ravindra
About Muniswamy Ravindra
Data last updated:
Muniswamy Ravindra is a Director at Proteogen Health Sciences India Private Limited (since 2018). The company operates in Healthcare. Proteogen Health Sciences India Private Limited reported revenue of ₹1.52 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Proteogen Health Sciences India Private Limited U74999KA2018PTC111140 | Director | 14 Mar 2018 | 2018 | ₹1.52 Cr (FY 2024) | Active |
Board colleagues of Muniswamy Ravindra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ganesh Babu Vsrinivasan | 03500752 | Proteogen Health Sciences India Private Limited | Director |
| Mahesh Krishnareddy | 08085767 | Proteogen Health Sciences India Private Limited | Director |
| Ramachandran Prakasam | 10101276 | Proteogen Health Sciences India Private Limited | Director |
| Sridhar Krishna Reddy | 05225540 | Proteogen Health Sciences India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Muniswamy Ravindra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Muniswamy Ravindra
Muniswamy Ravindra currently holds 1 directorship: Proteogen Health Sciences India Private Limited (Director, since 14 Mar 2018, revenue ₹1.52 Cr (FY 2024)).
Muniswamy Ravindra was first appointed on 14 Mar 2018 as Director at Proteogen Health Sciences India Private Limited.
The current boards of Muniswamy Ravindra's companies include Ganesh Babu Vsrinivasan (Proteogen Health Sciences India Private Limited), Mahesh Krishnareddy (Proteogen Health Sciences India Private Limited), Ramachandran Prakasam (Proteogen Health Sciences India Private Limited), Sridhar Krishna Reddy (Proteogen Health Sciences India Private Limited).